Bryan Egge
Director Business Development, Due Diligence at Novartis | Boston, Massachusetts, United States
Engage
candidates 10x faster
Enjoy unlimited access and discover candidates outside of LinkedIn
Trusted by 1.4M users from 76% of Fortune 500 companies
The most accurate data ever
CCPA Compliant
GDPR Compliant
150M
Personal Emails
200M
Work Emails
100M
Direct Dials
250M
Professional Profiles
40M
Company Profiles
Find anyone, anywhere
with ContactOut
today
Making remote or global hires?
Connecting
with key decision-makers? We can help.
- 40 emails / month
- 3 phone numbers / month
- Works on standard LinkedIn only
-
Work emails, personal emails,
mobile numbers
No credit card required
Bryan Egge serves as the Director of Due Diligence at Novartis Innovative Medicines, where he leverages over 13 years of scientific expertise in assay and biomarker development, translational and clinical oncology, and quality operations to drive strategic business initiatives. In his current role, Bryan is pivotal in leading global cross-functional due diligence teams, ensuring that evaluations are not only robust and balanced but also timely across various development units. His deep understanding of the pharmaceutical industry enables him to effectively assess potential in-licensing opportunities, mergers and acquisitions, and partnerships, making him a key partner for Business Development and Licensing (BD&L).
Bryan's leadership in due diligence is characterized by his meticulous approach to project management and data analysis, allowing him to synthesize complex information into actionable insights. His extensive background in high throughput screening and biomarker development informs his evaluations, ensuring that Novartis remains at the forefront of innovation in oncology. Additionally, Bryan’s expertise in vendor management and Lean Six Sigma methodologies enhances operational efficiency, enabling his teams to navigate the intricacies of corporate and business development with agility.
Currently, Bryan is involved in several high-impact projects that aim to identify and evaluate promising therapeutic candidates, ensuring that Novartis continues to expand its portfolio with cutting-edge solutions. His unique blend of scientific acumen and business insight positions him as a vital asset in driving Novartis’s mission to improve patient outcomes through innovative medicines.
Director Business Development, Due Diligence at Novartis in November 2023 to Present
Associate Director of Operations QA at Novartis in July 2019 to November 2023
Translational BioAssay and Clinical Vendor Manager at bluebird bio in November 2018 to May 2019
Scientist II at Novartis Institutes for BioMedical Research (NIBR) in September 2018 to November 2018
Scientist I at Novartis Institutes for BioMedical Research (NIBR) in April 2016 to August 2018
Scientific Associate II at Novartis Institutes for BioMedical Research (NIBR) in April 2014 to April 2016
Senior Associate at Amgen in February 2011 to March 2014
Biologist II at Merck in February 2010 to January 2011
Research Technician/Lab Manager at University of Massachusetts Medical School in May 2008 to January 2010
Research Undergraduate at University of Massachusetts Medical School in May 2007 to February 2008
See more
See less
Radioligand Binding
Gene Therapy
Business Development and Licensing
Clinical Laboratory Improvement Amendments (CLIA)
Project Management
Molecular Biology
Cell Culture
Drug Discovery
Cell Biology
Protein Chemistry
In Vitro
Data Analysis
PCR
Biotechnology
Cancer
Oncology
Clinical Development
Good Laboratory Practice (GLP)
Life Sciences
Pharmaceutical Industry
Quality Assurance
Good Clinical Practice (GCP)
Continuous Improvement
ISO Standards
Integration
Due Diligence
Business Development
Drug Development
CRO Management
High Throughput Screening
Antibodies
Biomarkers
HTRF
Luminex
siRNA
Biacore
SPR
In Vivo
Biomarker Development
Biomarker Discovery
Sample Management
GxP
Viral (BSL-2) Infectivity and Neutralization
In/out Licensing
Business Alliance Development
Lean Six Sigma
GCLP
See more
See less
Discover more about NovartisWhat is Bryan Egge email address?
Email Bryan Egge at [email protected]. This email is the most updated Bryan Egge email found in 2026.
What is Bryan Egge phone number?
Bryan Egge phone number is +16035718961.
How to contact Bryan Egge?
To contact Bryan Egge send an email to [email protected]. If you want to call Bryan Egge try calling on +16035718961. (updated on October 30, 2024)
What company does Bryan Egge work for?
Bryan Egge works for Novartis
What is Bryan Egge's role at Novartis?
Bryan Egge is Director Business Development, Due Diligence
What industry does Bryan Egge work in?
Bryan Egge works in the Pharmaceutical Manufacturing industry.
Bryan Egge Email Addresses
Bryan Egge Phone Numbers
looking for?
Find personal and work emails for over 250M professionals.
People like Bryan Egge
Systems Administrator & Network Engineer at Spun Gold Management & QC Storage
Information Security Analyst at South Carolina Division of Information Security
Operations Manager at AnewGreen
Vice President, NM Performance & Growth at Neiman Marcus Group
Founding Partner, CIO/CCO at Alpine Hill Advisors
Senior Account Executive at Latino Communications, LLC / Que Pasa Media Network
Sales Expert at Tesla
National Sales Manager at Food Service Specialties
Area Business Director at Ardelyx, Inc.
Relationship Manager & Lending Specialist NMLS ID 2168228 at Bank of America
Owner and Writer at Disney from Indiana
IT Inventory Tech at Intuitive Technology Group
Partner Group Engineering Manager, Office Product Group at Microsoft
Senior Director - Klamath Energy at Avangrid Renewables
Designer at Cuningham Group
Associate Software Engineer at Lockheed Martin
Adjunct Instructor at Shannon Duffy Training
Area Manager at StimLabs
Manager, Development- Real Estate at Lightsource bp
Child Protective Specialist at NYC Children Services
Show more
Show less